ELDN Insider Trading Activity and SEC Form 4 Filings
ELDN insider trading summary
No open-market insider purchases or sales of Eledon Pharmaceuticals, Inc. (ELDN) have been reported on SEC Form 4 in the past 12 months.
Latest ELDN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 9, 2024 | Bvf I Gp LLC | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Biotechnology Value Fund II LP | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Biotechnology Value Trading Fund OS LP | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | BVF Partners OS Ltd. | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Bvf Partners L P/Il | 10% Owner | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Biotechnology Value Fund L P | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Bvf II Gp LLC | Insider | Buy | $0 (1,031,385 @ $0.00) |
| May 9, 2024 | Bvf Partners L P/Il | 10% Owner | Buy | $0 (821,121 @ $0.00) |
| May 9, 2024 | Bvf II Gp LLC | Insider | Buy | $0 (75,431 @ $0.00) |
| May 9, 2024 | Biotechnology Value Fund II LP | Insider | Buy | $0 (75,431 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.